| 000 | 01095 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513084955.0 | ||
| 264 | 0 | _c19960314 | |
| 008 | 199603s 0 0 eng d | ||
| 022 | _a0340-6245 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSamama, M M | |
| 245 | 0 | 0 |
_aThrombolytic therapy: future issues. _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cJul 1995 |
||
| 300 |
_a106-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadverse effects |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoconjugates _xtherapeutic use |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aPulmonary Embolism _xdrug therapy |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xadverse effects |
| 700 | 1 | _aAcar, J | |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 74 _gno. 1 _gp. 106-10 |
|
| 999 |
_c8577500 _d8577500 |
||